Medtech analyst chides Erin Brockovich’s crusade against Bayer’s birth control implant

Analysts chide Erin Brockovich's crusade against Bayer's birth control implant

Healthcare giant Bayer (PINK:BAYRY) has another ally in the battle over its Essure contraceptive implant, with medical device analyst Joseph Gregory coming out against high-profile public advocate Erin Brockovich and her new interest in a growing outcry against the Essure procedure.

Gregory called Brockovich’s claims against Essure "inappropriate" and "unsubstantiated," saying that the arguments against Essure fail to appreciate the less-than-1% apparent major adverse event rate and the thousands of patients helped by the device.

"While the reported adverse cases are very serious and represent potential issues with the Essure device, or the procedure itself, they have to be considered in reference to how many patients in total have utilized and benefitted from this procedure," Gregory said in an official statement sent to "Although the adverse event profile may seem immensely large when highlighted, it isn’t large enough to surpass 1%."

"This doesn’t mean that Ms. Brockovich should stop being a resource for women who are interested in undergoing the procedure, or who have a medical story to share," he added. "However, her resources would be better directed to where the evidence supports her argument."

There are some 800 reported cases of adverse events associated with Essure, among around 16,300 physicians who have performed the procedure at least once, Gregory said. Even assuming that each of these physicians had only performed ten of these procedures in total, this provides an estimated US procedural volume of 163,000. That suggests an adverse event rate of about 0.5%, a figure that falls in line with more than 200 published reports on Essure’s performance.

Brockovich, the activist made famous by Julia Roberts’ portrayal in a 2000 blockbuster film, announced last month that she was taking an interest in Bayer and the Essure device after her organization was inundated with hundreds of inquiries from women who claimed the device had left them with serous issues. The reports included chronic pain, including colon perforations caused by movement of the device, implants that have been lost and are no longer visible on scans, pregnancies despite the presence of the implants and debilitating headaches, according to Brockovich’s website.

Brockovich called for a wide-scale recall of the Essure devices and for Bayer to conduct a thorough investigation into patient injury claims, a move that Gregory chided.

"For Ms. Brockovich to suggest that the device ‘does not work’ is to deprive it of its excellent performance in the estimated 15,500 patients who were adverse event-free," Gregory wrote. "Decisions to recall must be made on evidence-based results, not anecdotal information."

Gregory’s support joins comments made by FDA regulators, who said last month that the rising tide of Essure complaints of extreme fatigue, depression, weight-gain and other issues associated with the implant aren’t supported by real-world results.

The FDA said that it reviewed adverse event and complications reports, 5-year post-approval study results and clinical literature on Essure, concluding that there was no reason to believe that the device was connected to the new complaints. The agency added that Essure is 99.83% effective as a means of permanent sterilization, and that rare cases of sterilization failure, as well as certain post-treatment problems, are known issues listed in the product’s labeling.

Essure is part of the product portfolio that Bayer acquired in the $1.1 billion buyout of Conceptus, which the companies announced earlier this year. Conceptus won FDA approval for Essure in 2002.

Essure is a permanent form of birth control, comprised of flexible inserts that are implanted in the fallopian tubes where scar tissue forms around them. Essure is the only permanent contraceptive option that requires no incisions, the FDA said, and the device contains no hormones and can be placed without need for anesthesia.

RSS From Medical Design & Outsourcing

  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]
  • Saelig introduces Multiple Instrument System MIS4 universal test system
    Saelig Company has introduced the ABI Electronics’ Multiple Instrument Station MIS4, an all-in-one testing tool that provides all commonly required test instruments in one compact programmable hardware module, mounted in a compact case or installed in a PC-drive bay. Controlled by ABI’s sophisticated SYSTEM 8 Ultimate PC software with a simple yet programmable operator interface, […]
  • AssurX announces document management software update for small to mid-size companies in FDA regulated industries
    AssurX, an enterprise quality management, risk and regulatory compliance solution provider, announces the release of the latest update to their AssurX document management software. The document management solution provides a cost-effective solution for small to medium sized companies faced with streamlined operations and is fully compliant for FDA regulated industries. Ideal solution for small to […]
  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]

Leave a Reply